<DOC>
	<DOCNO>NCT00978328</DOCNO>
	<brief_summary>The purpose study describe clinical demographic characteristic patient receive prescription medication contain oxycodone immediate release ( OXYRX ) , characterize patient prescriber perception effectiveness outcomes tolerability OXYRX treatment , describe prescriber decision-making pain management Schedule II opioid explore prescribers identify suspect abuse pain medication .</brief_summary>
	<brief_title>Oxycodone User Registry ( OUR )</brief_title>
	<detailed_description>Real-world utility Schedule II immediate release opioids depend efficacy side effect . Few exist data source systematically capture opioid-related side effect impact patient outcome physician practice . This study expect lead in-depth understanding patient prescriber perception effectiveness side effect associate medication contain widely prescribe oral Schedule II immediate release opioid pain management , oxycodone immediate release ( OXYRX ) , alone ( eg , Roxicodone® ) combination ( eg , Percocet® , Tylox® ) actual clinical practice . This prospective , multi-center , observational patient registry . Adult outpatient pain due non-cancerous condition meeting study eligibility enrol . Prescribers treat patient accord usual practice . Prescribers treat patient , meet study eligibility , OXYRX accord usual practice .</detailed_description>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Pain require treatment Schedule II immediate release opioid within 3 day follow baseline visit pain warrant treatment prescription OXYRX PRN ( alone combination ) least 5 day baseline visit Use Schedule II opioid within 30 day prior inform consent plan use opioids ( Schedule IIV ) use OXYRX malignancy superficial skin cancer ( ie , basal cell , squamous cell ) within past year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Pain condition</keyword>
	<keyword>Oxycodone immediate release</keyword>
	<keyword>Percocet® , Tylox®</keyword>
	<keyword>Roxicodone®</keyword>
	<keyword>Registry</keyword>
	<keyword>Side effect</keyword>
	<keyword>Observational</keyword>
	<keyword>Pain management</keyword>
</DOC>